Carson Wealth (CWM LLC)
STAB

Carson Wealth (CWM LLC)’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-150
Closed – – 4501
2022
Q4 		$0 Sell
150
-4,300
-97% -$546 ﹤0.01% 4378
2022
Q3 		$1K Hold
4,450
– – ﹤0.01% 3860
2022
Q2 		$1K Buy
4,450
+4,000
+889% +$1.03K ﹤0.01% 3726
2022
Q1 		$0 Hold
450
– – ﹤0.01% 4006
2021
Q4 		$1K Buy
+450
New +$1.33K ﹤0.01% 3447
2021
Q2 		$2K Hold
438
– – ﹤0.01% 2735
2021
Q1 		$2K Hold
438
– – ﹤0.01% 2735
2020
Q4 		$2K Hold
438
– – ﹤0.01% 2734
2020
Q3 		$2K Hold
438
– – ﹤0.01% 2733
2020
Q2 		$2K Hold
438
– – ﹤0.01% 2731
2020
Q1 		$2K Hold
438
– – ﹤0.01% 2731
2019
Q4 		$2K Hold
438
– – ﹤0.01% 2729
2019
Q3 		$2K Hold
438
– – ﹤0.01% 2729
2019
Q2 		$2K Hold
438
– – ﹤0.01% 2728
2019
Q1 		$2K Buy
+438
New +$645 ﹤0.01% 2724

Other funds holding STAB

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Carson Wealth (CWM LLC)'s STAB Position: Q1 2023 in Review

Carson Wealth (CWM LLC) sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 150 shares.

Carson Wealth (CWM LLC) first reported a position in STAB in Q1 2019 and held it in 15 quarters. The position peaked at $2K in Q2 2021. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

  • Carson Wealth (CWM LLC) reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 150 Statera Biopharma, Inc. Common Stock shares in Q1 2023.
  • Carson Wealth (CWM LLC) first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Carson Wealth (CWM LLC)'s Statera Biopharma, Inc. Common Stock position peaked at $2K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2023, filed 1 May 2023.